Well‐controlled disease activity with drug treatment will not improve the frailty status of RA patients to robust state: A multicenter observational study (T‐FLAG)
Objectives To investigate a plateau in treatment enhancement for improving the frailty status of rheumatoid arthritis (RA) patients. Methods A total of 345 RA patients who were not robust in 2021 were assigned to the improved (“robust 2022,” n = 51) and non‐improved (“pre‐frailty/frailty 2022,” n = ...
Gespeichert in:
Veröffentlicht in: | International journal of rheumatic diseases 2024-01, Vol.27 (1), p.e14946-n/a |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objectives
To investigate a plateau in treatment enhancement for improving the frailty status of rheumatoid arthritis (RA) patients.
Methods
A total of 345 RA patients who were not robust in 2021 were assigned to the improved (“robust 2022,” n = 51) and non‐improved (“pre‐frailty/frailty 2022,” n = 294) groups. Factors associated with “robust 2022” were examined by logistic regression analysis. Patients were assigned to the stable (Follow‐up mean DAS28‐ESR in 2020 and 2021 |
---|---|
ISSN: | 1756-1841 1756-185X |
DOI: | 10.1111/1756-185X.14946 |